Follow RSS for latest reports on this topicTesticular Cancer - Market Research and Reports

Testicular cancer represents only 1 per cent of all cancers in men, but it is the single biggest cause of cancer-related deaths in men aged 15-35 years in the UK. The causes of testicular cancer and reasons are unknown. Exposure to female hormones in the environment, in water (possibly from the oral contraceptive pill in water supplies) has been suggested. Undescended testicles are a major risk factor.

There are two main types of testicular tumour - seminomas and non-seminomatous germ cell tumours (NSGCT, often also called 'teratomas'). The two types are about equally common. Seminomas are fairly smooth tumours and account for some 60 per cent of testicular tumours but teratomas are more complex and may contain different types of tissue.

Both types of tumour are capable of producing hormones (or proteins) that are detectable in the blood, eg human chorionic gonadotrophin (hCG). Teratomas can produce alpha-fetoprotein (AFP). Often the level of these proteins in the blood is useful in the diagnosis, treatment and follow-up of testicular cancer.

One of the great successes of modern chemotherapy has been the treatment of germ cell tumours. Usually four courses are given, at three-weekly intervals, of bleomycin, etoposide and cisplatin (BEP). The cure rate is 99% if caught early enough, largely due to successful treatments called cisplatin and carboplatin, which is now the standard treatment for seminoma.

Scientists made a breakthrough in 2010 in studying the origins of testicular cancer by grafting human tissue into mice. They have been able to study the development of the cells, which can cause testicular germ cell cancer (TGCC). In the latest study, published in the journal Human Reproduction, experts formulated a new method for investigating how human testes develop in baby boys before they are born. They took testicular tissue from donated foetuses and grafted it into mice, watching how the cells developed, as if inside a womb, over a six week period. Professor Richard Sharpe of the Medical Research Council (MRC) Human Reproductive Sciences Unit in Edinburgh and supervisor of the study, said: "This vital work... will help us to investigate whether common environmental chemicals, that foetuses are exposed to in the womb, play a role in the development of testicular cancer."

Source; The Independent

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Engineered T Cells Market by Type (Tumor Infiltrating Lymphocytes, T Cell Receptor, and Chimeric Antigen Receptor), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Leukemia, and Others), and End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023 [Report Updated: 01-01-2018]

T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient’s body to reduce toxicity levels and restrict antigen escape (inability of immune system to respon...Read More >>>

Published:
2018-01-01

Published by: Allied Market Research

Prices Starting From:
$3840

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022 [Report Updated: 01-08-2017]

“Global companion diagnostics market projected to grow at CAGR of 20.1%”The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, a...Read More >>>

Published:
2017-08-01

Published by: MarketsandMarkets

Prices Starting From:
$5650

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

Oncology Drugs market covers drugs that are used in the treatment of a wide range of cancer, sarcoma, and tumor. Some of the bestselling oncology drugs in 2016 include Avastin, Herceptin, Revlimid, MabThera/Rituxan, Gleevac/Glivec, Alimta, Zytiga, Tasigna, Sandostatin, and Afinitor.


The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$5370

Published:
2017-03-30

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

Published:
2017-03-30

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$5370

Published:
2016-08-02

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

Published:
2016-08-02

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Male Infertility Treatment Market: By Techniques (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, SPA, Sperm Agglutination, CASA),By Disorders (Idiopathic, varicocele, chryptrochidism, Obstructions, Testicular failure, Semen Disorders) & By Region-Forecast (2016-2021) [Report Updated: 26-02-2016]

Male infertility can be defined as the inability to cause pregnancy in a fertile female by male counterpart. Generally male infertility is caused due to low sperm count, hormonal problem or presence of low number of motile sperms. Fertile male requires normal functioning of hypothalamus, pituitary gland, and testes. However some of the other common causes of increasing infertility in male includes...Read More >>>

Published:
2016-02-26

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2016-02-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$6400

Published:
2016-01-22

Published by: Industry ARC

Prices Starting From:
$5250

Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2017-2022) [Report Updated: 18-07-2015]

Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save s...Read More >>>

Published:
2015-07-18

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2015-06-10

Published by: MarketsandMarkets

Prices Starting From:
$5650

Additional Searches

You may also like to search separately for: Testicular Cancer

We Stock...

{STICKYFOOTERMOBILE}